The launch of Dysport might spur a decrease in Botox prices over time; however, currently there has been no decrease in the cost of Botox to physician providers from Allergan. On the good side though, there has not been a cost increase for Botox as there had been in the past with high consumer demand.... more












478 posts
30 Apr 2009
Medicis is reporting today that Reloxin received FDA approval for Reloxin use in treatment of cervical dystonia in adults and glabellar lines in adults younger than 65